Clinical Trial Update: To Evaluate the Efficacy and Safety of TG-1000 Compared With Placebo in Adult Patients With Acute Uncomplicated Influenza Virus Infection [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating TG-1000 versus placebo for efficacy and safety in adults with acute uncomplicated influenza.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Virus Infection

Drugs mentioned

• TG-1000

Snippet

Sponsor: TaiGen Biotechnology Co., Ltd. | Conditions: Influenza Virus Infection | Phase 2 | Status: COMPLETED